Recall record at a glance
| Official record | F-1552-2022 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Ongoing |
| Recalling firm | Kabobs Acquisition Inc. |
| Report date | Aug 24, 2022 |
| Recall initiation date | Jul 14, 2022 |
| Quantity | 98cs/3/60 ct trays |
| Location | Lake City, GA, United States |
Official product description
Kabobs The Hors d'oeuvre Specialist TOMATO, BASIL & MASCARPONE ARANCINI 180 COUNT Prepared by: Kabobs, Inc., 5423 North Lake Dr., Lake City, GA 30260
Why the product was recalled
The firm was notified by their rice supplier that the product may contain small pieces of glass.
Distribution information
Product was shipped to the following states: GA, IL, KY, MA, MO, NJ, NY, RI, TX & UT.
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.